Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Home » Launch of the Innovative Health Initiative: opportunities for patient engagement
The Innovative Health Initiative (IHI) has started its activities with an official launch event on 26 January 2022. The IHI builds on the successes of the Innovative Medicines Initiative (IMI). The IHI is Europe’s new public-private partnership for health between the European Union and the European life science industries. The IHI’s goal is to support health research. It aims to translate health research and new ideas into real benefits for patients and society.
There are currently two involvement opportunities for patients, carers and patient organisations:
Stay up to date about opportunities on the IMI website: https://www.ihi.europa.eu/
Watch the recording of the launch event: https://www.ihi.europa.eu/news-events/events/introducing-innovative-health-initiative-europes-new-partnership-health
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79